UP!

IDIX $24.5

IDIX target price
24.50
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2014-06-10 Reiterated Rating Morgan Stanley Equal Weight $24.50 to $5.00
2014-06-09 Upgrade Robert W. Baird Neutral to Outperform
2014-06-09 Upgrade JMP Securities Market Perform
2014-01-30 Lower Price Target JMP Securities $5.00 to $3.00
2014-01-27 Downgrade JMP Securities Market Perform to Underperform $25.00
2014-01-10 Reiterated Rating Barclays Equal Weight $4.00 to $5.00
2013-10-16 Upgrade Credit Suisse Underperform to Neutral
2013-06-21 Downgrade Robert W. Baird Neutral to Underperform
2013-02-12 Initiated Robert W. Baird Neutral $5
2012-06-14 Initiated Maxim Group Buy $11
2012-04-30 Upgrade JMP Securities Mkt Underperform to Mkt Perform
2012-02-10 Initiated Barclays Capital Equal Weight $10
2012-01-09 Downgrade JMP Securities Mkt Perform to Mkt Underperform
2011-02-10 Downgrade ThinkEquity Hold to Sell $3 to $2
2011-02-10 Downgrade Oppenheimer Outperform to Perform
2010-09-08 Downgrade JMP Securities Mkt Outperform to Mkt Perform
2010-07-14 Initiated Stifel Nicolaus Buy $9
2010-05-07 Upgrade JMP Securities Mkt Perform to Mkt Outperform $8
2014-06-10 Reiterated Rating Morgan Stanley Equal Weight $24.50 to $5.00
2014-06-09 Upgrade Robert W. Baird Neutral to Outperform
2014-06-09 Upgrade JMP Securities Market Perform
2014-01-30 Lower Price Target JMP Securities $5.00 to $3.00
2014-01-27 Downgrade JMP Securities Market Perform to Underperform $25.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In IDIX 0 funds of 2213 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
NOVARTIS AG INDIRECT 10% OWNER 21.99%  (33320674) ALNY / IDIX /
Renaud Ronald C JR Chief Financial Officer 0.06%  (89990) AKBA / CMRX / IDIX / PTCT /
Standring David EVP, Biology 0.04%  (67375) IDIX /
HODGSON THOMAS R 0.04%  (57200) IDIX / TRV /
Weidenbruch John Ex. VP, Gen. Counsel and Secr. 0.02%  (35000) IDIX /